An OXA-48-producing Escherichia coli isolated from a Danish patient with no hospitalization abroad

Infectious Diseases
Anne GedebjergMikala Wang

Abstract

Carbapenemase-producing organisms are disseminating globally and are now emerging as a worrying threat in Scandinavia. Before August 2013, OXA-48-producing organisms had not been detected in Danish patients. Here we report the isolation of an ST746 OXA-48-producing Escherichia coli with the plasmid pOXA-48a carrying the blaOXA-48 gene isolated from a Danish patient without history of hospitalization abroad. The patient reported tourist travel to Egypt and Turkey. The potential acquisition of carbapenemase-producing organisms by ingestion of contaminated food is discussed.

References

Apr 6, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M A Leverstein-van HallUNKNOWN National ESBL surveillance group
Sep 8, 2011·Journal of Travel Medicine·Gisele PeiranoJohann D D Pitout
Nov 16, 2011·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Apr 14, 2012·The Journal of Antimicrobial Chemotherapy·Laurent PoirelPatrice Nordmann
Aug 10, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A PotronP Nordmann
Oct 5, 2013·Clinical Microbiology Reviews·Paul-Louis WoertherAntoine Andremont
Nov 5, 2013·International Journal of Food Microbiology·Guido M VoetsJames Cohen Stuart
Apr 18, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·E RuppéS Matheron
Jun 25, 2014·Emerging Infectious Diseases·Joseph E RubinChampika Fernando

❮ Previous
Next ❯

Citations

Oct 11, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Assia MairiAziz Touati
Oct 22, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Iman DandachiJean-Marc Rolain
Nov 30, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Marie-Hélène Nicolas-ChanoineUNKNOWN “E-carb Study Group”

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.